The Endologix ® AFX ® 2 Endovascular AAA System is indicated for endovascular treatment in patients with AAA using a surgical vascular access technique. The devices are indicated for patients with suitable aneurysm morphology for endovascular repair, including: Adequate iliac/femoral access compatible with the required delivery systems ...

On December 6, 2022, the FDA approved new labeling for the currently available product, the AFX2 Endovascular AAA System (AFX2), that includes information to better inform patients and health...

The AFX2 Endovascular AAA System is indicated for endovascular treatment in patients with AAA using a surgical vascular access technique or a bilateral percutaneous technique. The devices are indicated for patients with suitable aneurysm morphology for endovascular repair, including:

With a low-profile hydrophilic sheath, next-generation expanded polytetrafluoroethylene (ePTFE) graft technology, and a precise deployment mechanism for accuracy, the device system offers a promising new technology for EVAR patients. As the name implies, AFX is based on the proven concept of anatomical fixation, which has been shown to provide ...

2017年7月8日 · Endovascular abdominal aortic aneurysm repair (EVAR) with the AFX Endovascular AAA system is performed for symptomatic or asymptomatic aortic aneurysm greater than 5.5 cm in men and 5 cm in women with suitable anatomy. This chapter describes indications, essential steps, variations, and complications of this procedure.

In recent years, endovascular aortic repair (EVAR) has emerged as a safe and valid option for treatment of abdominal aortic aneurysms (AAAs) (Multimedia Appendix 1). The AFX 2 Endovascular AAA System (Endologix, Irvine, CA) consists of two components: an implantable stent graft and a disposable delivery catheter.

Methods: This retrospective, single-center study included 134 consecutive AAA patients who underwent endovascular aneurysm repair (EVAR) using the AFX unibody endograft paired with suprarenal aortic cuffs from Endologix (n=86) or Medtronic (n=48) between November 2011 and November 2022.

November 4, 2021—The Circulatory System Devices Panel of the Medical Device Advisory Committee of the FDA Center for Devices & Radiological Health held a 2-day meeting to address the use of endovascular aortic repair (EVAR) devices for the treatment of abdominal aortic aneurysms (AAAs).

The Endologix ® AFX ® 2 Endovascular AAA System is indicated for endovascular treatment in patients with AAA using a surgical vascular access technique or a bilateral percutaneous technique. The devices are indicated for patients with suitable aneurysm morphology for endovascular repair, including: Adequate iliac/femoral access compatible ...

Use of the AFX ® Endovascular System (Endologix) in proximal necks with significant thrombosis provides an additional degree of procedural flexibility and is supported by extensive clinical evidence. The system is based on a combination of the high-columnar-strength bifurcated unibody and proximal endografts.